Global Blood Glucose Measurement Market : Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015 to 2020 and Forecast 2021 to 2027

$ PRICE - $ 3,000.00$ 8,900.00

Blood Glucose Measurement Market: By product ( Self-Glucose Measurement Devices ( Blood Glucose Meter, Blood Glucose Testing Strips, Lancets, Others) Continuous Glucose Measurement Devices ) By end-user ( Hospitals , Diagnostic Centres, Home Settings, Others) Geography.

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Diabetes mellitus is group of diseases which affects blood sugar (glucose) levels in the body. Glucose is very important for the health as it’s a vital energy source of the cells which is helpful to build the muscles and tissues. Blood Glucose Measurement Market is one of the source to fuel the brain activities. Diabetes is characterised by increased levels of glucose in the blood. Blood glucose measuring devices helps the patients and healthcare professionals in measuring the glucose levels in the blood. Blood glucose monitoring devices market is driven by the high incidence of diabetes worldwide. According to the World Health Organisation (WHO), prevalence of the diabetes among adults about 18 years, risen from 4.7% to 8.5% from2012 to 2014 and diabetes is the 7th leading cause of the death. In addition to this factors, rise in advancements in technology like evolution in the continuous glucose monitoring devices are boosting the growth of blood glucose monitoring devices market. Moreover, rise in demand of portable self-glucose measuring devices, rise in investments and activities in R&D and funds from the government in preventing and treating diabetes are boosting the growth of the blood glucose measurement devices. Frequent product recalls of glucose testing strips owing to the manufactural defects and supplying of test strips which are, less differentiation products among the self-blood glucose monitors are some of the factors which are hampering the growth of the blood glucose measurement devices. Due to limited facilities of reimbursement and availability of alternative treatments which includes cell based assays, identification of biomarkers and artificial pancreas and high costs of the devices are the few threats for the growth of market.

Blood Glucose Measurement Market

MARKET SUMMARY
-
  • Study Period– 2021 – 2027
  • Base Year– 2020
  • CAGR– x%
  • Largest Market– Europe
  • Fastest Growing Market– North America

Blood Glucose Measurement Market

  • The report on global blood glucose measurement devices market gives historical, current and future market sizes (US$ Mn) based on product type, end user and region.
  • blood glucose measurement devices market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Nipro Diagnostics, Inc.
  • Abbott Laboratories
  • Medtronic
  • Bayer AG
  • Terumo Medical Corporation
  • Dexcom, Inc.
Blood Glucose Measurement Market

Drivers And Restraints

Market players are investing heavily to innovate products in order to maintain their position in the market, acquisitions and collaborations are the key strategies are used by the market players in order to increase the market share of the companies. For example, in 2017, Abbott Laboratories entered an agreement with Bigfoot Biomedical to commercialize and develop the diabetes management systems and also a Switzerland based company Ascensia Diabetes Care entered partnership with Medtronic to develop and market the diabetes management solutions.


North-America got significant share

Blood Glucose Measurement Market

Geographically blood glucose measurement market is divided into five key regions Asia- Pacific, North America, Middle East & Africa, Europe and Latin America. North America expected to be the leader in blood glucose measurement market and expected to have a significant growth rate during the forecast period. Europe region is also expected to show a notable rate of growth due to the changes in lifestyle and rise in adaption of home care diagnosis. Asia-Pacific region due to growing awareness about diabetes consequences like cardiac related issues are contributing the regions to show a significant growth. Initiatives taken by the government and non-government organizations in order to spread the awareness about the early diagnosis of diabetes, changes in lifestyle, large pool of patients are expected to drive the blood glucose measurement market growth.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Notable Market Developments

  • In 2016, Roche launched the Accu-Chek® Guide, the next-gen blood glucose monitoring system
  • In 2013, a Norway based manufacturer Prediktor Medical, developed a wearable device for estimating the blood glucose levels with dynamic models advanced and multivariate analysis and for interaction of insulin or glucose

Key

Report Outline

Blood Glucose Measurement Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content

1. Executive Summary
2. Global Blood Glucose Measurement Devices Market Introduction
2.1. Global Blood Glucose Measurement Devices Market – Taxonomy
2.2. Global Blood Glucose Measurement Devices Market –Definitions
2.2.1. Device Type
2.2.2. End User
3. Global Blood Glucose Measurement Devices Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Blood Glucose Measurement Devices Market Dynamic Factors – Impact Analysis
4. Global Blood Glucose Measurement Devices Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Blood Glucose Measurement Devices Market, By Device Type, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.1. Self-Glucose Measurement Devices
5.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Continuous Glucose Measurement Devices
5.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
6. Global Blood Glucose Measurement Devices Market, By End User, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.1. Hospitals
6.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Diagnostic Centers
6.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Home Settings
6.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Others
6.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. Global Blood Glucose Measurement Devices Market Forecast, By Region, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.1. North America
7.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Blood Glucose Measurement Devices Market – Opportunity Analysis Index, By Device Type, By End User, and Region, 2018 – 2024
8. North America Blood Glucose Measurement Devices Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.1. Device Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.1.1. Self-Glucose Measurement Devices
8.1.1.1. Blood Glucose Meter
8.1.1.2. Blood Glucose Testing Strips
8.1.1.3. Lancets
8.1.1.4. Others
8.1.2. Continuous Glucose Measurement Devices
8.2. End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.2.1. Hospitals
8.2.2. Diagnostic Centres
8.2.3. Home Settings
8.2.4. Others
8.3. Country Analysis 2016 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
8.3.1. U.S.
8.3.2. Canada
8.4. North America Blood Glucose Measurement Devices Market – Opportunity Analysis Index, By Device Type, By End User, and Country, 2018 – 2024
8.5. North America Blood Glucose Measurement Devices Market Dynamics – Trends
9. Europe Blood Glucose Measurement Devices Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
9.1. Device Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Self-Glucose Measurement Devices
9.1.1.1. Blood Glucose Meter
9.1.1.2. Blood Glucose Testing Strips
9.1.1.3. Lancets
9.1.1.4. Others
9.1.2. Continuous Glucose Measurement Devices
9.2. End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.2.1. Hospitals
9.2.2. Diagnostic Centres
9.2.3. Home Settings
9.2.4. Others
9.3. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.3.1. Germany
9.3.2. UK
9.3.3. France
9.3.4. Spain
9.3.5. Italy
9.3.6. Russia
9.3.7. Poland
9.3.8. Rest of Europe
9.4. Europe Blood Glucose Measurement Devices Market – Opportunity Analysis Index, By Device Type, By End User, and Country, 2018 – 2024
9.5. Europe Blood Glucose Measurement Devices Market Dynamics – Trends
10. Asia-Pacific Blood Glucose Measurement Devices Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
10.1. Device Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Self-Glucose Measurement Devices
10.1.1.1. Blood Glucose Meter
10.1.1.2. Blood Glucose Testing Strips
10.1.1.3. Lancets
10.1.1.4. Others
10.1.2. Continuous Glucose Measurement Devices
10.2. End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Hospitals
10.2.2. Diagnostic Centres
10.2.3. Home Settings
10.2.4. Others
10.3. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.3.1. Japan
10.3.2. China
10.3.3. India
10.3.4. ASEAN
10.3.5. Australia & New Zealand
10.3.6. Rest of Asia-Pacific
10.4. Asia-Pacific Blood Glucose Measurement Devices Market – Opportunity Analysis Index, By Device Type, By End User, and Country, 2018 – 2024
10.5. Asia-Pacific Blood Glucose Measurement Devices Market Dynamics – Trends
11. Latin America Blood Glucose Measurement Devices Market Analysis, 2012 – 2012 – 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
11.1. Device Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Self-Glucose Measurement Devices
11.1.1.1. Blood Glucose Meter
11.1.1.2. Blood Glucose Testing Strips
11.1.1.3. Lancets
11.1.1.4. Others
11.1.2. Continuous Glucose Measurement Devices
11.2. End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Hospitals
11.2.2. Diagnostic Centres
11.2.3. Home Settings
11.2.4. Others
11.3. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Argentina
11.3.4. Venezuela
11.3.5. Rest of Latin America
11.4. Latin America Blood Glucose Measurement Devices Market – Opportunity Analysis Index, By Device Type, By End User, and Country, 2018 – 2024
11.5. Latin America Blood Glucose Measurement Devices Market Dynamics – Trends
12. Middle East and Africa Blood Glucose Measurement Devices Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
12.1. Device Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Self-Glucose Measurement Devices
12.1.1.1. Blood Glucose Meter
12.1.1.2. Blood Glucose Testing Strips
12.1.1.3. Lancets
12.1.1.4. Others
12.1.2. Continuous Glucose Measurement Devices
12.2. End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Hospitals
12.2.2. Diagnostic Centres
12.2.3. Home Settings
12.2.4. Others
12.3. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.3.1. Gulf Cooperation Council (GCC) Countries
12.3.2. Israel
12.3.3. South Africa
12.3.4. Rest of MEA
12.4. MEA Blood Glucose Measurement Devices Market – Opportunity Analysis Index, By Device Type, By End User, and Country, 2018 – 2024
12.5. MEA Blood Glucose Measurement Devices Market Dynamics – Trends
13. Competition Landscape
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. Nipro Diagnostics, Inc. (U.S.)
13.2.2. Abbott Laboratories (U.S.)
13.2.3. ARKRAY (Japan)
13.2.4. Medtronic (U.S.)
13.2.5. Bayer AG (Germany)
13.2.6. Dexcom, Inc. (U.S.)
13.2.7. F. Hoffmann-La Roche Ltd (Switzerland)
13.2.8. Johnson and Johnson Services Inc. (U.S.)
13.2.9. Terumo Medical Corporation (U.S.)
14. Research Methodology
15. Key Assumptions and Acronyms


Report

Company Profile

  • Abbott Laboratories (U.S.)
  • ARKRAY (Japan)
  • Medtronic (U.S.)
  • Bayer AG (Germany)
  • Dexcom, Inc. (U.S.)
  • Hoffmann-La Roche Ltd (Switzerland)
  • Johnson and Johnson Services Inc. (U.S.)
  • Terumo Medical Corporation (U.S.)

Description

Diabetes mellitus is group of diseases which affects blood sugar (glucose) levels in the body. Glucose is very important for the health as it’s a vital energy source of the cells which is helpful to build the muscles and tissues. Blood Glucose Measurement Market is one of the source to fuel the brain activities. Diabetes is characterised by increased levels of glucose in the blood. Blood glucose measuring devices helps the patients and healthcare professionals in measuring the glucose levels in the blood. Blood glucose monitoring devices market is driven by the high incidence of diabetes worldwide. According to the World Health Organisation (WHO), prevalence of the diabetes among adults about 18 years, risen from 4.7% to 8.5% from2012 to 2014 and diabetes is the 7th leading cause of the death. In addition to this factors, rise in advancements in technology like evolution in the continuous glucose monitoring devices are boosting the growth of blood glucose monitoring devices market. Moreover, rise in demand of portable self-glucose measuring devices, rise in investments and activities in R&D and funds from the government in preventing and treating diabetes are boosting the growth of the blood glucose measurement devices. Frequent product recalls of glucose testing strips owing to the manufactural defects and supplying of test strips which are, less differentiation products among the self-blood glucose monitors are some of the factors which are hampering the growth of the blood glucose measurement devices. Due to limited facilities of reimbursement and availability of alternative treatments which includes cell based assays, identification of biomarkers and artificial pancreas and high costs of the devices are the few threats for the growth of market.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX